POSSIBLE EPIGENETIC CHANGES THAT COULD DRIVE PLATINUM RESISTANCE IN HIGH GRADE SEROUS OVARIAN CARCINOMA: DATA FROM AN IN-VITRO TREATMENT MODEL

被引：0
|
作者：
Ergasti, Raffaella [1 ,2 ]
Lim, Mi Qi [2 ]
Giannone, Gaia [2 ]
Ennis, Darren P. [2 ]
Dye, Isabel C. A. [2 ]
Mirza, Hasan B. [2 ]
Russo, Giorgia [1 ,2 ]
Fagotti, Anna [1 ,3 ]
Scambia, Giovanni [1 ,3 ]
Mcneish, Iain [2 ]
机构：
[1] Fondazione Policlinico Univ Agostino Gemelli IRCC, Rome, Italy
[2] Imperial Coll London, London, England
[3] Univ Cattolica Sacro Cuore, Rome, Italy
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2023年 / 33卷
关键词：
D O I：
10.1136/ijgc-2023-ESGO.782
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
597
引用
收藏
页码：A369 / A370
页数：2
相关论文
共 40 条
  • [1] Transcriptomic and epigenetic changes in ovarian high grade serous carcinoma after platinum treatment: results from an in vitro model
    Russo, Giorgia
    Ergasti, Raffaella
    Lim, Mi Qi
    Mirza, Hasan
    Giannone, Gaia
    Ennis, Darren P.
    Dye, Isabel C. A.
    Marchetti, Claudia
    Fagotti, Anna
    Scambia, Giovanni
    Mcneish, Iain
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A514 - A515
  • [2] Epigenetic alterations driving platinum resistance relapse in high grade serous ovarian carcinoma at transcriptomic level
    Ergasti, Raffaella
    Russo, Giorgia
    Lim, Mi Qi
    Giannone, Gaia
    Ennis, Darren P.
    Dye, Isabel Ca
    Mirza, Hasan B.
    Marchetti, Claudia
    Fagotti, Anna
    Scambia, Giovanni
    Mcneish, Iain
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A503 - A503
  • [3] Dissecting the immune microenvironment in a High Grade Serous Ovarian Cancer murine model following Platinum treatment and epigenetic modulation
    De Luca, Michele
    Basso, Francesca
    Belletti, Barbara
    Colombo, Mario Paolo
    Mezzanzanica, Delia
    Baldassarre, Gustavo
    Jachetti, Elena
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 1187 - 1187
  • [4] TP53 mutations and the association with platinum resistance in high grade serous ovarian carcinoma
    Montemorano, Lauren
    Shultz, Zoey B.
    Farooque, Alma
    Hyun, Meredith
    Chappell, Richard J.
    Hartenbach, Ellen M.
    Lang, Jessica D.
    GYNECOLOGIC ONCOLOGY, 2024, 186 : 26 - 34
  • [5] A multi-omic analysis to identify epigenetic drivers of platinum-resistance in high-grade serous ovarian carcinoma models
    Adams, Kristin
    Moreno, Ryan
    Wendt, Jae-Rim
    Wood, Josie
    Roopra, Avtar
    Lang, Jessica D.
    CANCER RESEARCH, 2024, 84 (05)
  • [6] Changes in HRD status during treatment for ovarian high-grade serous carcinoma
    Matsumura, Noriomi
    Takaya, Hisamitsu
    Takamatsu, Shiro
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S140 - S140
  • [7] Epigenetic alteration of RASSF1a distinguishes high grade from low grade ovarian serous carcinoma
    Wang, L
    Hui, P
    Liu, W
    Zhang, X
    Hart, WR
    Yang, B
    MODERN PATHOLOGY, 2006, 19 : 200A - 201A
  • [8] Epigenetic alteration of RASSF1a distinguishes high grade from low grade ovarian serous carcinoma
    Wang, L
    Hui, P
    Liu, W
    Zhang, X
    Hart, WR
    Yang, B
    LABORATORY INVESTIGATION, 2006, 86 : 200A - 201A
  • [9] CAF-associated signaling pathways are linked to platinum resistance in high-grade serous ovarian carcinoma
    Wessolly, Michael
    Mairinger, Elena
    Borchert, Sabrina
    Bankfalvi, Agnes
    Mach, Pawel
    Schmid, Kurt Werner
    Kimmig, Rainer
    Burderath, Paul
    Maringer, Fabian Dominik
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 255 - 256
  • [10] Reversing platinum resistance in high-grade serous ovarian carcinoma: targeting BRCA and the homologous recombination system
    Wiedemeyer, W. Ruprecht
    Beach, Jessica A.
    Karlan, Beth Y.
    FRONTIERS IN ONCOLOGY, 2014, 4
1234